ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982

In Brief: First CREG Announcement Due In Late April For In Vitro Carcinogen Test Improvements

March 21, 1975

NCI Provides $40 Million To Four Centers For Cancer Communications Research.

June 27, 2003

NIH Emerges From Republican Revolution With Another Increase in Appropriations

October 4, 1996

Bill To Teach Breast Self-Exam To Teens Wins Political Support; Experts Fear Harm

April 10, 2009